Diadema Partners »

Miragen Therapeutics shares owned by Diadema Partners

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $657k 21k 31.12

More positions owned by Diadema Partners

Viking Therapeutics (VKTX)
Vertex Pharmaceuticals Incorporated (VRTX)
Bridgebio Pharma (BBIO)
Spdr Series Trust State Street Spd Put Option (XBI)
Praxis Precision Medicines I Com New Put Option (PRAX)
Johnson & Johnson (JNJ)
Avidity Biosciences Ord Call Option (RNA)
Capricor Therapeutics Com New (CAPR)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Jazz Pharmaceuticals Shs Usd Call Option (JAZZ)
Terns Pharmaceuticals (TERN)
Apogee Therapeutics Call Option (APGE)
Structure Therapeutics Sponsored Ads Call Option (GPCR)
Regeneron Pharmaceuticals (REGN)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Diadema Partners

Top funds holding Miragen Therapeutics

FMR
BlackRock
Vanguard Group
Bellevue Group
Fairmount Funds Management
VR Adviser
State Street Corporation
Deep Track Capital
Novo A/S
Geode Capital Management
Alliancebernstein
Tang Capital Management
Eversept Partners
Fisher Investments
Baker Bros. Advisors

View all funds holding Miragen Therapeutics